SGFY Signify Health Inc

As filed with the Securities and Exchange Commission on March 29, 2023

No. 333-253115

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-253115

UNDER

THE SECURITIES ACT OF 1933

SIGNIFY HEALTH, INC. 2021 LONG-TERM INCENTIVE PLAN

SIGNIFY HEALTH, INC. EMPLOYEE STOCK PURCHASE PLAN

SIGNIFY HEALTH, INC. AMENDED AND RESTATED 2012 EQUITY INCENTIVE PLAN

SIGNIFY HEALTH, INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN

CURE AGGREGATOR, LLC INCENTIVE UNIT AGREEMENTS

(Full title of the plans)

Kyle Armbrester

Chief Executive Officer

Signify Health, Inc.

4055 Valley View Lane, Suite 700

Dallas, Texas 75244

(Name and address of agent for service)

(855) 984-5121

(Telephone number, including area code, of agent for service)

With a copy to:

Andrew B. Barkan, Esq.

Fried, Frank, Harris, Shriver & Jacobson LLP

One New York Plaza

New York, New York 10004

(212) 859-8000

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

DEREGISTRATION OF SECURITIES

This Post-Effective Amendment No. 1 (the “Post-Effective Amendment”) relates to the Registration Statement on Form S-8 (Registration No. 333-253115) previously filed by Signify Health, Inc., a Delaware corporation (“Signify”), with the U.S. Securities and Exchange Commission on February 16, 2021 (the “Registration Statement”), covering:

On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated as of September 2, 2022 (the “Merger Agreement”), by and among Signify, CVS Pharmacy, Inc. (“Parent”), a Rhode Island corporation and a wholly owned subsidiary of CVS Health Corporation, and Noah Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Subsidiary”), Merger Subsidiary merged with and into Signify, with Signify surviving as a wholly owned subsidiary of Parent.

In connection with the consummation of the transactions contemplated by the Merger Agreement, Signify has terminated all offerings of its securities pursuant to the above-referenced Registration Statement. In accordance with the undertakings made by Signify in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities that had been registered which remain unsold at the termination of the offering, Signify, by filing this Post-Effective Amendment, hereby terminates the effectiveness of the Registration Statement and removes from registration any and all securities registered but unsold under the Registration Statement as of the date hereof. The Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities.